Spotlight
-
Updated NCCN Guideline Recommends Tivozanib Regimen in Clear Cell Renal Cell Carcinoma
Christoph Baker Mar 29 | 2021 National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib)…
Read More » -
Guidelines for Kidney Cancer Treatment
A list of global guidelines for kidney cancer are provided in this section. These guidelines provide evidence-based recommendations to serve as a guide…
Read More » -
COVID – 19 and Cancer Resources
Here’s the latest information and resources to support patients with cancer, clinicians, and researchers within cancer care delivery team… We…
Read More »
